![Torgeir Vaage](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Torgeir Vaage
Finanzdirektor/CFO bei INITIATOR PHARMA A/S
Aktive Positionen von Torgeir Vaage
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
INITIATOR PHARMA A/S | Finanzdirektor/CFO | 01.01.2016 | - |
Investor Relations Kontakt | - | - | |
Caerus Capital AS
![]() Caerus Capital AS Pharmaceuticals: MajorHealth Technology Caerus Capital AS develops a process to produce heparin from marine raw materials. It focuses on developing novel anticoagulant agents based on biomass from the fish farming industry. The firm's technological platform is based on patented processes for extraction and purification of heparin using marine species-specifically salmon intestines-as raw material. The company was founded by Ragnar Flengsrud on December 4, 2001 and is headquartered in Hovik, Norway. | Vorstandsvorsitzender | - | - |
Vorsitzender | - | - | |
Caerus Consulting AS
![]() Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway. | Vorstandsvorsitzender | 31.03.2009 | - |
Vorsitzender | 31.03.2009 | - | |
Gründer | 31.03.2009 | - | |
Finanzdirektor/CFO | 31.03.2009 | - | |
GeneSeque AS
![]() GeneSeque AS Medical SpecialtiesHealth Technology GeneSeque AS provides single-molecule DNA-sequencing technology. It develops MagSeq, a break-through technology for single-molecule sequencing. The company was founded on February 12, 2008 and is headquartered in Trondheim, Norway. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Torgeir Vaage
Ehemalige bekannte Positionen von Torgeir Vaage
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VoluSense AS
![]() VoluSense AS Medical SpecialtiesHealth Technology VoluSense AS manufactures medical devices focused on pulmonary health. It offers VoluSense Pediatrics in the neonatal unit for the infants that provides visual and quantitative information on tidal flow, tidal volume, minute volume, and respiration frequency. The company was founded by Kjell Gunnar Øygarden and is headquartered in Bergen, Norway. | Geschäftsführer | - | - |
ABG SUNDAL COLLIER HOLDING ASA | Corporate Officer/Principal | - | - |
Handelsbanken Markets Norge
![]() Handelsbanken Markets Norge Investment Banks/BrokersFinance Part of Svenska Handelsbanken AB, Handelsbanken Markets Norge is a Norwegian company that provides security brokerage services. | Corporate Officer/Principal | - | - |
Sana Pharma Medical AS
![]() Sana Pharma Medical AS Pharmaceuticals: MajorHealth Technology Sana Pharma Medical AS develops topical analgesic products. It develops products against various chronic pain conditions, including osteoarthritis of the knee. Its product 2PX provides clinical benefit in the management of both nociceptive and neuropathic pain. The company was founded in 2002 and is headquartered in Oslo, Norway. | Finanzdirektor/CFO | - | - |
Ausbildung von Torgeir Vaage
Norwegian School of Economics & Business Administration | Graduate Degree |
University of California, Berkeley | Doctorate Degree |
Statistik
International
Norwegen | 9 |
Vereinigte Staaten | 2 |
Dänemark | 2 |
Operativ
Director of Finance/CFO | 3 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ABG SUNDAL COLLIER HOLDING ASA | Finance |
INITIATOR PHARMA A/S | Health Technology |
Private Unternehmen | 6 |
---|---|
Sana Pharma Medical AS
![]() Sana Pharma Medical AS Pharmaceuticals: MajorHealth Technology Sana Pharma Medical AS develops topical analgesic products. It develops products against various chronic pain conditions, including osteoarthritis of the knee. Its product 2PX provides clinical benefit in the management of both nociceptive and neuropathic pain. The company was founded in 2002 and is headquartered in Oslo, Norway. | Health Technology |
Handelsbanken Markets Norge
![]() Handelsbanken Markets Norge Investment Banks/BrokersFinance Part of Svenska Handelsbanken AB, Handelsbanken Markets Norge is a Norwegian company that provides security brokerage services. | Finance |
Caerus Capital AS
![]() Caerus Capital AS Pharmaceuticals: MajorHealth Technology Caerus Capital AS develops a process to produce heparin from marine raw materials. It focuses on developing novel anticoagulant agents based on biomass from the fish farming industry. The firm's technological platform is based on patented processes for extraction and purification of heparin using marine species-specifically salmon intestines-as raw material. The company was founded by Ragnar Flengsrud on December 4, 2001 and is headquartered in Hovik, Norway. | Health Technology |
Caerus Consulting AS
![]() Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway. | Health Technology |
VoluSense AS
![]() VoluSense AS Medical SpecialtiesHealth Technology VoluSense AS manufactures medical devices focused on pulmonary health. It offers VoluSense Pediatrics in the neonatal unit for the infants that provides visual and quantitative information on tidal flow, tidal volume, minute volume, and respiration frequency. The company was founded by Kjell Gunnar Øygarden and is headquartered in Bergen, Norway. | Health Technology |
GeneSeque AS
![]() GeneSeque AS Medical SpecialtiesHealth Technology GeneSeque AS provides single-molecule DNA-sequencing technology. It develops MagSeq, a break-through technology for single-molecule sequencing. The company was founded on February 12, 2008 and is headquartered in Trondheim, Norway. | Health Technology |
- Börse
- Insiders
- Torgeir Vaage
- Erfahrung